Authors
Latest:
New Long-Term KEYNOTE-716 Data Presented at ASCO 2023Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.
Latest:
Cancer Vaccine Plus Keytruda Improves Survival Without Relapse in Resected MelanomaFindings from a phase 2 trial showed improvements in relapse-free survival with an mRNA vaccine plus Keytruda compared with Keytruda alone in patients with high-risk resected melanoma.
Latest:
Anna López-Ferrer, MD, PhD, and Volker Koscielny, MD, MBA, Share Highlights From Almirall’s 15th Skin AcademyLópez-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.
Latest:
Improving Hidradenitis Suppurativa Outcomes by Addressing Treatment GapsPatients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help prevent tissue damage among patients.
Latest:
Expert Perspectives on BOLT clinical trial dataJohn Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Latest:
Resources for Patients With GPPBoni Elewski, MD, shares resources for patients with GPP, highlighting a team-based approach to meet the psychological and physical needs of the patient.
Latest:
FDA Grants Orphan Drug Status to ITIL-168 for MelanomaThe FDA has granted an Orphan Drug designation to the investigational tumor-infiltrating lymphocyte therapy ITIL-168 for the treatment of patients with stage IIB to IV melanoma.
Latest:
Navigating Nutrition Support For Patients With Atopic DermatitisAtoosa Kourosh, MD, MPH, delves into opportunities for allergists and dermatologists to collaborate, her approach to cases, and patient resources.
Latest:
Finding Balance in a Busy Conference SeasonKristina Collins, MD, delves into the importance of being present in the moments you have control over and making self-care a priority on the road.
Latest:
Preparing Patients for the Summer Sun: Location, Location, LocationLeading clinicians discuss sun protection best practices based on weather, climate, and travel needs.
Latest:
Acne Flares May be Worsened by Climate ChangeChanges in the cutaneous microbiome triggered by warmer temperatures and increased UV radiation may stimulate C. acnes growth.
Latest:
Advancing Medical Treatments for Vitiligo With Amit Pandya, MD, FAADPandya gives an in-depth overview of his vitiligo treatment pearls from the 2023 Pigmentary Disorders Exchange Symposium.
Latest:
Addressing Disparities in Inflammatory Skin Diseases in Darker Skin TonesAt AAD 2025, Raj Chovatiya, MD, PhD, MSCI, explored the role of social determinants in AD, HS, and PsO, emphasizing the need for improved clinical recognition and inclusive research.
Latest:
Female physicians earn millions less than male counterparts, new report findsA new study on the gender pay gap in medicine examined earnings data from more than 80,000 doctors.
Latest:
Acne Update: 2022’s Top 5 TrendsFresh spins on established treatments and newly FDA-approved drugs and devices provide a framework for changing therapies and modalities for acne regimens.
Latest:
Expert Insights Into the Relationship Between the Hippo Pathway and Extensive Fibrosis in HSResearchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.
Latest:
Mike Siegel, PhD: What's Coming Up in 2024 for PeDRAIn an interview with Dermatology Times, the executive director of Pediatric Dermatology Research Alliance (PeDRA) discusses the group's growth since 2012 and what it can offer practicing dermatologists, researchers, students, and patients.
Latest:
Expert Perspectives on BOLT clinical trial dataJohn Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Latest:
COVID-19 study shows impact on patients with PsO, other autoimmune problemsArdon Health patients with autoimmune conditions have expressed common questions and concerns about COVID-19.
Latest:
New Data on the Perception of Pregnancy-Related Skin ChangesMisinformation from outside sources creates unrealistic expectations for pregnancy and postpartum skin conditions like hyperpigmentation.
Latest:
Optimizing MOAs of JAK Inhibitors in a 36-Year-Old Male With a History of Atopic DermatitisJayme Heim, MSN, FNP-BC, explores strategies for optimizing the mechanisms of action of topical JAK inhibitors in treating a 36-year-old male patient with a history of atopic dermatitis, highlighting the potential benefits and considerations of this therapeutic approach.
Latest:
Provider and Patient Considerations for Prurigo Nodularis TreatmentMelodie Young, MSN, A/GNP-C, discusses how clinical and practical considerations, such as disease severity, patient preferences, and comorbidities, should guide the selection of treatment for prurigo nodularis, and emphasizes the importance of educating patients about the role of systemic therapies, addressing their concerns, and improving awareness of available treatment options.
Latest:
Photodynamic Pearls and Best PracticesMonica Boen, MD, discusses how implementing proven photodynamic therapy techniques and adhering to best practices can significantly improve treatment outcomes and patient satisfaction.
